William L. Macias
2023
In 2023, William L. Macias earned a total compensation of $1.9M as Chief Medical Officer at Immunovant, a 72% decrease compared to previous year.
Compensation breakdown
| Bonus | $210,000 |
|---|---|
| Option Awards | $636,078 |
| Salary | $500,000 |
| Stock Awards | $562,952 |
| Other | $9,876 |
| Total | $1,918,906 |
Macias received $636.1K in option awards, accounting for 33% of the total pay in 2023.
Macias also received $210K in bonus, $500K in salary, $563K in stock awards and $9.9K in other compensation.
Rankings
In 2023, William L. Macias' compensation ranked 538th out of 2,647 executives tracked by ExecPay. In other words, Macias earned more than 79.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 538 out of 2,647 | 80th |
Division Manufacturing | 305 out of 1,447 | 79th |
Major group Chemicals And Allied Products | 213 out of 817 | 74th |
Industry group Drugs | 210 out of 783 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 75 out of 204 | 63rd |
Source: SEC filing on June 26, 2023.
Macias' colleagues
We found two more compensation records of executives who worked with William L. Macias at Immunovant in 2023.